TDP1; | |
NR1H4; | |
PPARA; | |
MAOB; | |
TLR2; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Oxidoreductase | MAOB | Monoamine oxidase B | P27338 | CHEMBL2039 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0051704; multi-organism process | GO:0002237; response to molecule of bacterial origin | 3.482E-05 | 1.610E-01 | MAOB, NR1H4, TLR2 |
BP | GO:0050896; response to stimulus | GO:0050727; regulation of inflammatory response | 7.805E-05 | 1.610E-01 | NR1H4, PPARA, TLR2 |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 6.274E-05 | 1.610E-01 | NR1H4, PPARA |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 9.118E-05 | 1.610E-01 | NR1H4, PPARA |
MF | GO:0005488; binding | GO:0008289; lipid binding | 4.066E-04 | 1.789E-01 | NR1H4, PPARA, TLR2 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 7.764E-04 | 1.848E-01 | NR1H4 |
CC | Unclassified; | GO:0106003; amyloid-beta complex | 2.844E-03 | 3.260E-01 | TLR2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09105 Amino acid metabolism | hsa00360 | Phenylalanine metabolism | 4.243E-03 | 4.190E-02 | MAOB |
09160 Human Diseases | 09164 Substance dependence | hsa05030 | Cocaine addiction | 1.219E-02 | 4.190E-02 | MAOB |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.368E-02 | 4.190E-02 | TLR2 |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 1.664E-02 | 4.190E-02 | MAOB |
09160 Human Diseases | 09162 Immune diseases | hsa05321 | Inflammatory bowel disease (IBD) | 1.615E-02 | 4.190E-02 | TLR2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.713E-02 | 4.190E-02 | MAOB |
09150 Organismal Systems | 09152 Endocrine system | hsa04920 | Adipocytokine signaling pathway | 1.738E-02 | 4.190E-02 | PPARA |
09160 Human Diseases | 09167 Infectious diseases | hsa05140 | Leishmaniasis | 1.812E-02 | 4.190E-02 | TLR2 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.713E-02 | 4.190E-02 | PPARA |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.763E-02 | 4.190E-02 | NR1H4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|